SH served as a speaker, a consultant, an advisory board member, and/or has received travel grants from Pfizer, Janssen, AbbVie, Takeda, Ferring, Pharmacosmos, Banook Group, and Galapagos/Alpha Sigma. BC has received lecture and/or consulting fees from AbbVie, Amgen, Celltrion, Ferring, Galapagos, Janssen, Lilly, Pfizer, and Takeda. JEO reports institutional research grants from Pfizer. KP received lecture/speaker fees from Physicians Education Resource LLC and Grifols; scientific advisory board fees from ProciseDx Inc and Scipher Medicine Corporation; and serves as a consultant for Prometheus Laboratories Inc. DJ has received speaker fee from Johnson and Johnson. KBG has received grants from Pfizer Inc., Galapagos, and Celltrion; consultancy fees from AbbVie, Arena Pharmaceuticals, Galapagos, Gilead, Immunic Therapeutics, Janssen Pharmaceuticals, Novartis, Pfizer Inc., Samsung Bioepis, and Takeda; and speaker’s honoraria from Celltrion, Ferring, Janssen Pharmaceuticals, Novartis, Pfizer Inc, Samsung Bioepis, Takeda, and Tillotts, all outside the submitted work. MAS has received personal fees from Takeda, Janssen, Sandoz, MSD, Falk, Samsung Bioepis, Galapagos, and Bristol Myers Squibb. PMI reports research grants from Celltrion, Pfizer Inc., Takeda Pharmaceutical Company, and Galapagos; consulting fees from AbbVie Inc., Arena Pharmaceuticals, Boehringer Ingelheim, Bristol Myers Squibb, Celltrion, Elasmogen Ltd, Gilead Sciences Pty Ltd, Janssen Pharmaceuticals, Eli Lilly and Company, Pfizer Inc., Prometheus, and Sandoz; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from AbbVie Inc., Bristol Myers Squibb, Celgene, Celltrion, Dr Falk Pharma, Galapagos, Gilead Sciences Inc., Janssen Pharmaceuticals, Eli Lilly and Company, Pfizer Inc., Takeda Pharmaceutical Company, and Tillotts Pharma AG; and support for attending meetings and/or travel from AbbVie and Tillotts Pharma AG. MPS has received educational grants or research support from Ferring, Orphan, and Gilead; speaker’s fees from Janssen, Abbvie, Ferring, Takeda, Pfizer, and Shire; and served on advisory boards for Janssen, Takeda, Pfizer, Celgene, Abbvie, MSD, and Emerge Health. KK has served as speaker, consultant and advisory board member for Abbvie, Amgen, Ferring, Galenica, Genesis, Janssen, MSD, Pfizer, Takeda, and Vianex ID has received consultation fees, research grants, or honoraria from Janssen, Pfizer, Abbvie, Takeda, Genentech/Roche, Ferring, Iterative Scopes, Integra Holdings, Eli Lilly, Falk Pharma, Gilead, Galapagos, Celgene/BMS, Arena, Sublimity, Sangamo, Sandoz, Celltrion, Abbott, Prometheus, Altman, and Athos; Shareholder: Harp Diagnostics and GUTREAT. LPB reports fees received from: AbbVie, Adacyte, Alimentiv, Alma Bio Therapeutics, Amgen, Applied Molecular Transport, Arena, Biogen, BMS, Celltrion, CONNECT Biopharm, Cytoki Pharma, Enthera, Ferring, Fresenius Kabi, Galapagos, Genentech, Gilead, Gossamer Bio, GSK, HAC-Pharma, IAG Image Analysis, Index Pharmaceuticals, Inotrem, Janssen, Lilly, Medac, Mopac, Morphic, MSD, Norgine, Nordic Pharma, Novartis, OM Pharma, ONO Pharma, OSE Immunotherapeutics, Pandion Therapeutics, Par’Immune, Pfizer, Prometheus, Protagonist, Roche, Sanofi, Sandoz, Takeda, Theravance, Thermo Fisher, Tigenix, Tillots, Viatris, Vifor, Ysopia, Abivax, Samsung, Ventyx, Roivant, and Vectivbio. The remaining authors have no conflicts to disclose.